130 related articles for article (PubMed ID: 22348853)
1. Coleman, Coyle, Shuping, and Rue make false statements and draw erroneous conclusions in analyses of abortion and mental health using the National Comorbidity Survey.
Steinberg JR; Finer LB
J Psychiatr Res; 2012 Mar; 46(3):407-8; discussion 408-11. PubMed ID: 22348853
[No Abstract] [Full Text] [Related]
2. Examining the association of abortion history and current mental health: A reanalysis of the National Comorbidity Survey using a common-risk-factors model.
Steinberg JR; Finer LB
Soc Sci Med; 2011 Jan; 72(1):72-82. PubMed ID: 21122964
[TBL] [Abstract][Full Text] [Related]
3. Induced abortion and anxiety, mood, and substance abuse disorders: isolating the effects of abortion in the national comorbidity survey.
Coleman PK; Coyle CT; Shuping M; Rue VM
J Psychiatr Res; 2009 May; 43(8):770-6. PubMed ID: 19046750
[TBL] [Abstract][Full Text] [Related]
4. Abortion and mental health: findings from The National Comorbidity Survey-Replication.
Steinberg JR; McCulloch CE; Adler NE
Obstet Gynecol; 2014 Feb; 123(2 Pt 1):263-270. PubMed ID: 24402590
[TBL] [Abstract][Full Text] [Related]
5. [Other mental disorders presenting together with schizophrenia].
Koponen H; Moilanen K; Isohanni M
Duodecim; 2003; 119(1):43-9. PubMed ID: 12607471
[No Abstract] [Full Text] [Related]
6. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Grant BF; Stinson FS; Dawson DA; Chou SP; Dufour MC; Compton W; Pickering RP; Kaplan K
Arch Gen Psychiatry; 2004 Aug; 61(8):807-16. PubMed ID: 15289279
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
Gum AM; King-Kallimanis B; Kohn R
Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
[TBL] [Abstract][Full Text] [Related]
8. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
Hall W; Degenhardt L; Teesson M
Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Brady KT; Verduin ML
Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
McEvoy PM; Grove R; Slade T
Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
[TBL] [Abstract][Full Text] [Related]
11. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
Prior K; Mills K; Ross J; Teesson M
Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
Teesson M; Slade T; Mills K
Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
[TBL] [Abstract][Full Text] [Related]
13. Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders.
Hill KP
JAMA; 2017 Mar; 317(10):1070-1071. PubMed ID: 28291877
[No Abstract] [Full Text] [Related]
14. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
[TBL] [Abstract][Full Text] [Related]
15. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Conway KP; Compton W; Stinson FS; Grant BF
J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
[TBL] [Abstract][Full Text] [Related]
16. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
Schatzberg AF; Weiss RD; Brady KT; Culpepper L
CNS Spectr; 2008 Apr; 13(4 Suppl 6):3. PubMed ID: 18408653
[No Abstract] [Full Text] [Related]
17. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
[TBL] [Abstract][Full Text] [Related]
18. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing.
Reavley NJ; Cvetkovski S; Jorm AF; Lubman DI
Aust N Z J Psychiatry; 2010 Aug; 44(8):729-35. PubMed ID: 20636194
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric comorbidity of full and partial posttraumatic stress disorder among older adults in the United States: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
Pietrzak RH; Goldstein RB; Southwick SM; Grant BF
Am J Geriatr Psychiatry; 2012 May; 20(5):380-90. PubMed ID: 22522959
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
Olfson M; Blanco C; Wall MM; Liu SM; Grant BF
J Clin Psychiatry; 2019 May; 80(3):. PubMed ID: 31141319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]